A comparison of calcium, calcitriol, and alendronate in corticosteroid-treated premenopausal patients with systemic lupus erythematosus. [electronic resource]
Producer: 20090324Description: 2344-7 p. digitalISSN:- 0315-162X
- Adrenal Cortex Hormones -- adverse effects
- Adult
- Alendronate -- therapeutic use
- Bone Density
- Bone Density Conservation Agents -- therapeutic use
- Calcitriol -- therapeutic use
- Calcium -- therapeutic use
- Calcium Carbonate -- therapeutic use
- Female
- Humans
- Lupus Erythematosus, Systemic -- blood
- Osteoporosis -- chemically induced
- Premenopause
- Young Adult
No physical items for this record
Publication Type: Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.